Childhood cancer survival rates improve globally, but disparities persist due to uneven healthcare access
Original framing: “[Editorial] Childhood cancer: progress, but not enough” — The Lancet
Scientific advancements in chemotherapy, radiation, and targeted therapies have significantly improved survival rates in high-income countries. However, the application of these innovations is uneven, and scientific research often lacks representation from low-income regions.
The progress in childhood cancer survival is a result of scientific innovation and global health initiatives, but it is also shaped by deep historical and structural inequalities.
Indigenous and traditional knowledge systems offer underutilized resources for holistic care, while cross-cultural perspectives reveal the importance of culturally sensitive approaches. Marginalised voices must be centered in policy-making to address the systemic barriers that persist in low-income regions. Future strategies must integrate scientific advancements with community-based solutions, ensuring that no child is left behind due to geography, wealth, or culture. This requires a reimagining of global health governance that prioritizes equity, inclusion, and long-term sustainability.